Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 10 Neoplasm Metastasis 2 Prostate Adenocarcinoma 1 Metastatic Castration-resistant Prostate Cancer 1 Biochemical Recurrent Prostate Cancer 1

Interventions

Radiotherapy 3 Radiation 3 Magnetic Resonance Spectroscopy 3 relugolix 2 luprolide acetate gel depot 2 enzalutamide 2 bicalutamide 2 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2 Specimen Handling 2 Radiosurgery 2 Leuprolide 2 Goserelin 2 Biopsy 2 radium Ra 223 dichloride 1 niraparib 1 histrelin 1 gallium 68 PSMA-11 1 darolutamide 1 abiraterone 1 X-Rays 1 Triptorelin Pamoate 1 Surgical Procedures, Operative 1 Salicylic Acid 1 Radium-223 1 Radiotherapy, Image-Guided 1 Radiation Dose Hypofractionation 1 Proton Therapy 1 Prednisone 1 Lymph Node Excision 1 Glutamate Carboxypeptidase II 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Adenocarcinoma × Radium-223 × 1 year × Clear all

NCT04704505 2026-02-06

BAT-RAD

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡